Cochrane Abstracts
Prognostic value of test(s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Prognostic Value of Test(s) for O6‐methylguanine–DNA Methyltransferase (MGMT) Promoter Methylation for Predicting Overall Survival in People With Glioblastoma Treated With Temozolomide." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431926/all/Antibiotics_for_persistent_nasal_discharge__rhinosinusitis__in_children:_Cochrane_systematic_review. Accessed 23 April 2024.
Prognostic value of test(s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431926/all/Antibiotics_for_persistent_nasal_discharge__rhinosinusitis__in_children:_Cochrane_systematic_review. Accessed April 23, 2024.
Prognostic value of test(s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431926/all/Antibiotics_for_persistent_nasal_discharge__rhinosinusitis__in_children:_Cochrane_systematic_review
Prognostic Value of Test(s) for O6‐methylguanine–DNA Methyltransferase (MGMT) Promoter Methylation for Predicting Overall Survival in People With Glioblastoma Treated With Temozolomide [Internet]. In: Cochrane Abstracts. [cited 2024 April 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431926/all/Antibiotics_for_persistent_nasal_discharge__rhinosinusitis__in_children:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Prognostic value of test(s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide
ID - 431926
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431926/all/Antibiotics_for_persistent_nasal_discharge__rhinosinusitis__in_children:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
